Round 2: Adding Radiation Therapy vs Switching Treatments
04/24/2025
This round delves into the role of radiation therapy. Panelists weigh the relevance of traditional chemotherapy agents against the use of radiation therapy. The discussion explores patient selection, long-term toxicity, and whether certain populations may benefit from radiation-based regimens in an era of biologically driven care.
To hear arguments related to immunotherapy vs alternative therapy, see Round 1.
To hear arguments related to for TTFields vs against TTFields, see Round 3.
Transcript coming soon!
This is a non-CME activity. The views and opinions expressed by the presenter(s) do not necessarily reflect the views and opinions of the Oncology Learning Network, HMP Global, or its employees and affiliates.
Moderator: Corey Langer, MD
Director of Thoracic Oncology
Abramson Cancer Center
Hospital of the University of Pennsylvania
For Adding Radiation Therapy: Jamie E Chaft, MD
Thoracic Medical Oncologist
Memorial Sloan Kettering Cancer Center
For Switching Treatments: Edward Garon, MD
Thoracic Medical Oncologist
University of California
